Skip to main content
. 2024 Jun 12;16(6):3818–3827. doi: 10.21037/jtd-23-1598

Table 4. Subgroup analysis of 27 PLLs which were not diagnosed by rEBUS GS TBLB and underwent rEBUS GS TBNA.

Variables rEBUS GS TBNA P value
Diagnostic (n=5) Non-diagnostic (n=22)
Age, years 71±8 68±8 0.47
Gender >0.99
   Male 3 (60.0) 15 (68.2)
   Female 2 (40.0) 7 (31.8)
Lesion size, mm 20±4 21±14 0.83
Distribution by size >0.99
   ≤20 mm 3 (60.0) 13 (59.1)
   >20 mm 2 (40.0) 9 (40.9)
Distance from pleura, mm 21±21 13±14 0.32
Location of PLL 0.47
   Right upper lobe 1 (20.0) 7 (31.8)
   Right middle lobe 0 1 (4.5)
   Right lower lobe 0 3 (13.6)
   Left upper lobe 4 (80.0) 8 (36.4)
   Left lower lobe 0 3 (13.6)
Opacity of PLL on chest CT 0.58
   Subsolid opacity 2 (40.0) 5 (22.7)
   Solid opacity 3 (60.0) 17 (77.3)
Cavity formation on chest CT >0.99
   Present 0 1 (4.5)
   Absent 5 (100.0) 21 (95.5)
Bronchus sign on chest CT 0.30
   Present 3 (60.0) 18 (81.8)
   Absent 2 (40.0) 4 (18.2)
rEBUS visualization 0.047
   Within PLL 0 12 (54.5)
   Adjacent to PLL 5 (100.0) 10 (45.5)

Data are presented as n (%) or mean ± SD. CT, computed tomography; GS, guide sheath; PLL, peripheral lung lesion; rEBUS, radial endobronchial ultrasound; SD, standard deviation; TBLB, transbronchial lung biopsy; TBNA, transbronchial needle aspiration.